We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 13,768

USMCA Scales Back on Investor-State Arbitration but Preserves Trade Dispute Resolution in North America
  • Dechert LLP
  • USA, Mexico, Canada
  • October 12 2018

The United States, Canada and Mexico on September 30 announced the framework for a new, revised trade agreement to replace NAFTA, called the United


FAA Reauthorization Briefing Part 1: Airline Fee Issues
  • Cozen O'Connor
  • USA
  • October 11 2018

On October 5, 2018, President Trump signed into law the “FAA Reauthorization Act of 2018.” The Act, which has wide-ranging implications for the


The Long-Awaited Telemedicine Controlled Substance Prescribing Permit
  • Bryan Cave Leighton Paisner LLP
  • USA
  • October 11 2018

Last week, the United States Congress passed a 250-page bill addressing the opioid crisis entitled SUPPORT for Patients and Communities Act (the


Senate Bills Seek to Provide More Prescription Drug Cost Information to Consumers
  • Barnes & Thornburg LLP
  • USA
  • October 10 2018

The U.S. Senate recently passed two bipartisan bills related to prescription drugs. One, the “Know the Lowest Price Act of 2018” (S. 2553),” would


Top Labor Law Developments for August and September 2018
  • Jackson Lewis PC
  • USA
  • October 10 2018

Pearce’s nomination came despite widespread criticism from Republicans and business groups who viewed Pearce as having taken an anti-business approach


Politicians Seek Greater Online Consumer Privacy Protections
  • Duane Morris LLP
  • USA
  • October 10 2018

The Congressional mid-term elections are coming up. There is ample current discussion about whether the Republicans can hold onto majorities in both


More Than 700 CEOs of Hospitals and Health Systems Write to Congress to Stop Cuts to the 340B Drug Pricing Program
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • October 10 2018

On October 2, 2018, the CEOs of more than 700 hospitals and health systems representing healthcare providers in all fifty states sent a letter to


SEC Withdraws Support for Proxy Advisory Firms
  • Winston & Strawn LLP
  • USA
  • October 8 2018

Last month, the SEC released a Public Statement Regarding Staff Proxy Advisory Letters, concerning its upcoming Roundtable on the Proxy Process and


Washington Healthcare Update- 8 Oct, 2018
  • McGuireWoods Consulting LLC
  • USA
  • October 8 2018

D.C. obsessed with Supreme Court nomination; opioids legislation hits the president’s desk for signature; 340B continues to be of concern


Stern Challenge to Third-Party Plan Releases Fails in Delaware
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • October 5 2018

In hindsight, it seems inevitable that constitutional and other jurisdictional problems would arise when Congress, in enacting the Bankruptcy Reform